Why is the pharmaceutical industry turning its back on the UK? September 18, 2025 Since coming into power last year, Rachel Reeves and Keir Starmer have consistently stressed the importance of the life science sector to the UK economy, viewing it as critical for growth. In its aim to boost the industry’s standing, Labour pledged to make the UK an attractive place for investment and innovation, and to increase [...]
Astrazeneca pauses £200m Cambridge investment September 13, 2025 British drug giant Astrazeneca has paused a planned £200 million expansion of its research site in Cambridge in a fresh blow to the UK pharmaceutical industry. It comes after the pharmaceutical firm abandoned plans to invest £450 million in a vaccine plant in Merseyside earlier this year in a blow to the Government as it [...]
Merck warns UK is ‘not internationally competitive’ as it scraps £1bn London research centre September 10, 2025 Merck has pulled out of a planned £1bn London drug research centre in the latest blow to the government’s growth agenda. The US pharma giant is to lay off 127 staff alongside abandoning the construction project, which had been set to open in King’s Cross in 2027. The firm warned the UK would lag behind [...]
Swiss shares fall as the country feels the wrath of Trump’s tariffs August 4, 2025 Shares in Swiss firms dropped on Monday morning as markets digested the consequences of US president Donald Trump’s high tariffs. The Swiss Market Index dropped by 1.9 per cent to 11,835 francs upon opening this morning, before easing its losses to trade at 1.54 per cent down. It clawed its way back to 0.77 per [...]
Pharma stocks suffer as Trump demands prescription slash August 1, 2025 Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for American consumers. Trump’s threat against pharmaceuticals has given healthcare sector investors “a dose of the blues” after his letter to various company bosses. It outlined that they should either cut US prescription prices or face a tariff [...]
Astrazeneca plots huge $50bn US investment after ditching UK expansion plans July 22, 2025 Astrazeneca has unveiled plans to invest as much as $50bn in manufacturing and R&D in the US after ditching its UK expansion plans in a blow to the government’s industrial strategy. The Cambridge-based pharma giant said it will spend the huge sum over the next five years, including on a new manufacturing facility in Virginia, [...]
Trump tariffs: FTSE 100 holds steady as pharma and metals brace for levies July 9, 2025 The FTSE 100 opened 22 points up this morning, despite threats of pharma and metals tariffs with stark implications for major stocks on the blue chip index. President Trump has said that an announcement is coming “very soon” on pharmaceutical tariffs – with a possible 200 per cent rate landing in “about a year”. Major [...]
London Tech Week: Astrazeneca’s AI push could take humans out of the loop June 10, 2025 Astrazeneca unveiled an ambitious overhaul of its manufacturing and supply operations driven by deep tech, AI, and what it called a “self-healing” supply chain at London Tech Week. The firm claimed it’s laying the groundwork to become one of the top 10 most innovative and sustainable supply chains globally by 2030. But while the vision [...]
Invidior: Drug maker ditches London for US June 2, 2025 The London Stock Exchange suffered another blow on Monday after drug maker Invidior said it intends to abandon its London listing and focus on its primary listing in the US. The firm said it had reviewed its listing structure and considered liquidity, the location of shareholders and red tape associated with its London listing. Its [...]
GSK and Astrazeneca shares slump as Trump vows drug price cut May 12, 2025 GSK and Astrazeneca shares fall as Trump announces drug price cuts in a new executive order.